Patient-Linked Factors Associated with Delayed Reporting of Oral and Pharyngeal Carcinoma among Patients Attending National Cancer Institute, Maharagama, Sri Lanka

نویسندگان

  • Laurence Shreenikumari Alahapperuma
  • Eshani Anoja Fernando
چکیده

Background: Diagnosis of cancer at an early stage improves prognosis following treatment. Unfortunately a large proportion of oral and pharyngeal cancer patients are diagnosed at late stages which require radical treatment with considerable morbidity and mortality. Many researchers have examined different types of delay that could occur between the onset of symptoms and diagnosis. The objective of this research was to identify patient-linked delays between the time of first noticing symptoms and definitive diagnosis, and its association with the stage at diagnosis among oral and pharyngeal carcinoma patients attending the National Cancer Institute, Maharagama, Sri Lanka. Methods: A hospital-based descriptive cross-sectional study was carried out on 351 patients with histologically confirmed carcinoma of oral cavity and pharynx. Data were collected using an interviewer- administered questionnaire and a data extraction sheet. If a patient had taken more than three months to visit a Health Care Practitioner, it was considered as ‘Patient Delay-1’. If a patient had taken more than two weeks following referral to reach for specialized cancer care, it was considered as ‘Patient Delay 2’. Results: Proportions of ‘Patient Delay-1’ and ‘Patient Delay-2’ were 19% (n=252) and 16% (n=322) respectively. Mean time duration between noticing symptoms to definitive diagnosis was 14.1 weeks (SD=10.3). The proportion of advanced-stage cancers at diagnosis was 59.8%. Conclusion: Stage at diagnosis was significantly associated with ‘Patient Delay -1’ (p = 0.001) but not with ‘Patient Delay-2’. ‘Patient Delay-1’ was significantly associated with level of education (p = 0.001) and the cost of travelling (p = 0.048).

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Epidemiology of Oral and Pharyngeal Cancer at the National Cancer Institute, Cairo

Background: The epidemiology of oral and pharyngeal cancer has not been studied adequately in Egypt and other Arab countries. Many studies indicated the low survival of this cancer and delay in the diagnosis although it is easy to detect early without sophisticated equipments. Objectives: To determine the epidemiological characteristics and the risk factors of oral and pharyngeal cancer among a...

متن کامل

Oral Cancer Screening Knowledge of Sri Lankan Dentists

Oro-pharyngeal cancers are the most common type of cancer in Sri Lanka and accounts for 14.4% of all cancers. With an age-standardized incidence rate of 15.4/100,000 it is ranked first among all cancers in males and in females with an age-standardized incidence rate of 4.5/100,000 it is ranked fourth (Cancer Registry, 2002). Though the oral cavity is accessible to visual examination to patients...

متن کامل

Occupational Stress and Burnout Among Lawyers in Sri Lanka

The aim of this study was to explore the associations between occupational stress measured through job demand control (JDC), and burnout among lawyers in Sri Lanka. The job demand-control model and the burnout model are among the most used theoretical frameworks that relate job characteristics to health and well-being of individuals. This study included 290 respondent lawyers practicing in the ...

متن کامل

Epidemiology of oral and pharyngeal cancers: A retrospective study in ‎Kermanshah, Iran

BACKGROUND AND AIM: The aim of this study was to determine the incidence and relative frequency of oral and pharyngeal cancers in Kermanshah, Iran, from March 1993 until March 2006.METHODS: The data used in this epidemiologic study were extracted directly from pathology records registered in 12 (all) public and private pathology centers of Kermanshah province during the 13-year study period. Th...

متن کامل

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

INTRODUCTION AND AIMS Tamoxifen is an adjuvant drug effective in treating hormone receptor - positive breast cancer. However, 30%-50% of patients relapse and many develop adverse effects, such as hot flashes and fatty liver. Allelic variations altering the activity of cytochrome P450-2D6 enzyme affect response to tamoxifen by modulating metabolism of tamoxifen into its pharmacologically active ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 18  شماره 

صفحات  -

تاریخ انتشار 2017